IMCAS Academy

Introduction
Program
Speakers
Sponsor list
Accreditation

GO BACK

IMCAS World Congress 2022
Program

Adapt the schedule of the livestreamed class/congress to your time zone

Time zone reference: (UTC+02:00) Europe, Paris

Time zone

Time zone:Change time zone

If you are logged in, change your default time zone in your account

FOCUS ON S128

The Investors Forum

Focus program

Room: Amphi Havane - Level 3
Date: Saturday 4 June 2022 at 13:30 to 15:30
Format: ECONOMIC FORUM > talks dealing with market analysis and strategies of the medical field led by representatives of major medical companies, financial analysts, medical and economic journalists

Chairs

Humberto ANTUNES

Corporate finance

United States

Shimon ECKHOUSE

Industry Representative

Israel

Lectures of the session

Hours	Speakers	Lecture title	Abstract	Number
13:30		Introduction		113361
13:35	Michael GORTON	Keynote: telemedicine, where are we, where are we going?		113362
13:45	Fabrice TURCQ	The Bridgepoint experience in the minimally invasive surgery market		113369
13:55	Ethan RIGEL	What a venture capital skin health fund looks like		113370
14:05	Thierry CHIGNON	The view from Wall Street: public capital markets update		113371
14:15	Tom SEERY	The consumerization of aesthetics		113372
14:25	Shimon ECKHOUSE	The future of energy-based devices		113374
14:35	Prof Merete HAEDERSDAL	New trends in virtual solutions and diagnostics for the aesthetic market		113375
14:45	Charles RUBAN	Enabling investments in aesthetic medicine		113373
14:55		Roundtable discussion		114024
14:55	Natalene HOEPFFNER	Moderator		113376
14:55	Prof Mark Steven NESTOR	Moderator		113656
14:55	Humberto ANTUNES	Roundtable panelist		116170
14:55	Thierry CHIGNON	Roundtable panelist		113377
14:55	Shimon ECKHOUSE	Roundtable panelist		116171
14:55	Michael GORTON	Roundtable panelist		114023
14:55	Prof Merete HAEDERSDAL	Roundtable panelist		113757
14:55	Ethan RIGEL	Roundtable panelist		113379
14:55	Charles RUBAN	Roundtable panelist		116500
14:55	Tom SEERY	Roundtable panelist		113755
14:55	Fabrice TURCQ	Roundtable panelist		113756
14:55	Hubert ZAJICEK	Roundtable panelist		113378
15:25		Q&A and conclusion		113380

Go to previous session

Go to next session

Recommended sessions

Market analysis

Finance

Introduction

Michael GORTON

Industry Representative

United States

Other author(s) :

Keynote: telemedicine, where are we, where are we going?

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Fabrice TURCQ

Corporate finance

France

Other author(s) :

The Bridgepoint experience in the minimally invasive surgery market

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Ethan RIGEL

Corporate finance

United States

Other author(s) :

What a venture capital skin health fund looks like

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
Yes
Please specify entities (individual, company, society): I own the firm

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Thierry CHIGNON

Corporate finance

France

Other author(s) :

The view from Wall Street: public capital markets update

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Tom SEERY

Industry Representative

United States

Other author(s) :

The consumerization of aesthetics

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Shimon ECKHOUSE

Industry Representative

Israel

Other author(s) :

The future of energy-based devices

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Prof Merete HAEDERSDAL

Dermatologist

Denmark

Other author(s) :

New trends in virtual solutions and diagnostics for the aesthetic market

Disclosures

Did you receive any funding to support your research for this TOPIC?
Yes
Please specify entities (individual, company, society): studies&me

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Charles RUBAN

Industry Representative

France

Other author(s) :

Enabling investments in aesthetic medicine

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability